Replication and Amplification of Defective Interfering Particle RN As of Vesicular Stomatitis Virus in Cells Expressing Viral Proteins from Vectors Containing Cloned cDNAs by Pattnaik, Asit K. & Wertz, Gail W.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Papers in Veterinary and Biomedical Science Veterinary and Biomedical Sciences, Department of
6-1990
Replication and Amplification of Defective
Interfering Particle RN As of Vesicular Stomatitis
Virus in Cells Expressing Viral Proteins from
Vectors Containing Cloned cDNAs
Asit K. Pattnaik
University of Nebraska-Lincoln, apattnaik2@unl.edu
Gail W. Wertz
Follow this and additional works at: http://digitalcommons.unl.edu/vetscipapers
Part of the Biochemistry, Biophysics, and Structural Biology Commons, Cell and Developmental
Biology Commons, Immunology and Infectious Disease Commons, Medical Sciences Commons,
Veterinary Microbiology and Immunobiology Commons, and the Veterinary Pathology and
Pathobiology Commons
This Article is brought to you for free and open access by the Veterinary and Biomedical Sciences, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Papers in Veterinary and Biomedical Science by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.
Pattnaik, Asit K. and Wertz, Gail W., "Replication and Amplification of Defective Interfering Particle RN As of Vesicular Stomatitis
Virus in Cells Expressing Viral Proteins from Vectors Containing Cloned cDNAs" (1990). Papers in Veterinary and Biomedical Science.
199.
http://digitalcommons.unl.edu/vetscipapers/199
JOURNAL OF VIROLOGY, June 1990, p. 2948-2957 
0022-538X/90/062948-1O$02.00/0 
Copyright © 1990, American Society for Microbiology 
Vol. 64, No.6 
Replication and Amplification of Defective Interfering Particle RN As 
of Vesicular Stomatitis Virus in Cells Expressing Viral Proteins 
from Vectors Containing Cloned cDNAs 
ASIT K. PATTNAIK AND GAIL W. WERTZ· 
Department of Microbiology, University of Alabama at Birmingham Medical School, Birmingham, Alabama 35294 
Received 28 December 1989/Accepted 15 March 1990 
Replication and amplification of RNA genomes of defective interfering (DI) particles of vesicular stomatitis 
virus (VSV) depend on the expression of viral proteins and have untD now been attained only in ceUs coinfected 
with helper VSV. In the work described in this report, we used a recombinant vaccinia virus-T7 RNA 
polymerase expression system to synthesize individual VSV proteins in cells transfected with plasmid DNAs 
that contain cDNA copies of the VSV genes downstream of the T7 RNA polymerase promoter. In this way, we 
were able to examine the ability of VSV proteins, individually and in combination, to support DI particle RNA 
replication. VSV proteins were synthesized soon after transfection in amounts that depended on the amount of 
input plasmid DNA and at rates that remained constant for at least 16 h after transfection. When ceUs 
expressing the nucleocapsid protein (N), the phosphoprotein (NS), and the large polymerase protein (L) ofVSV 
were superiofected with the DI particles, rapid and efficient replication and amplification of DI particle RNA 
was observed. Omission of anyone of the three viral proteins abrogated the replication. The maximum levels 
of DI particle RNA replication that were achieved in the system exceeded those seen with wDd-type helper VSV 
by 8- to IO-fold and were observed at molar L:NS:N protein ratios of approximately 1:200:200. This replication 
system can be used for analysis of structure-function relationships of VSV proteins that are involved in RNA 
replication and has potential for use in the identification of RNA sequences in the viral genome that control 
transcription and replication of VSV RNA. 
Vesicular stomatitis virus (VSV), the prototype rhabdo-
virus, contains a single-stranded, negative-sense RNA of 
11,161 nucleotides (42, 43). The genomic RNA is complexed 
tightly with the nucleocapsid protein, N, to form the nucleo-
capsid structure. The active template for transcription and 
replication of the VSV genome is the nucleocapsid structure 
that contains two additional proteins, the large protein, L, 
and the phosphoprotein, NS, which constitute the viral 
polymerase (5, 6,13, 14, 18, 34). The nucleocapsid template 
is transcribed to generate a 47-nucleotide-Iong leader RNA 
and five monocistronic, capped and polyadenylated mRNAs 
in a sequential and attenuated manner (I, 4, 24, 42). These 
mRNAs are translated to produce the five structural proteins 
of VSV. In the presence of these viral proteins, the poly-
merase complex also directs the synthesis of full-length 
positive-sense RNA, which is found in infected cells only in 
the form of nucleocapsids (45). The positive-sense nucleo-
capsid template serves in tum as the template for the 
synthesis of progeny negative-sense RNA genomes. 
The two RNA synthetic events, transcription and replica-
tion, differ fundamentally in their requirements for viral 
protein synthesis. Transcription can occur in the absence of 
protein synthesis, whereas viral proteins must be synthe-
sized before genome RNA replication occurs (51). It was 
proposed that the nucleocapsid template (41) as well as an 
interaction of the N protein with the leader RNA sequences 
(2, 7) might regulate the switch from transcription to repli-
cation. 
Several in vitro systems were developed in past years to 
study the requirements for VSV RNA replication (10,11,21, 
33, 39). A permeable-cell system from VSV-infected cells 
(10) supports transcription and replication offull-Iength VSV 
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RNAs, which are assembled into nucleocapsid structures. 
Cell extracts prepared from VSV-infected cells (21,39) also 
support transcription as well as replication and assembly of 
both full-length positive- and negative-sense RNAs. Al-
though these systems support RNA replication, the protein 
synthesis requirements for RNA replication were difficult to 
investigate because of the presence of soluble protein pools 
in the cell extracts. 
To analyze the individual protein requirements for VSV 
RNA replication, a reconstituted in vitro system was devel-
oped (11, 48) which supported the synthesis of full-length 
genomic and antigenomic nucleocapsids of a defective inter-
fering (DI) particle in the presence of the viral proteins 
synthesized in response to the addition of individual mRNAs 
to the system (36). The use of the DI particle nUcleocapsid 
template is essential to the success of these analyses, be-
cause the DI particle lacks the genetic information for the 
complete N, NS, M, G, and L genes and hence cannot 
synthesize mRNAs which can feed into the system and 
complicate the analyses. By using this system, it was dem-
onstrated that the N protein alone fulfills the requirement for 
de novo protein synthesis for RNA replication (37). In 
subsequent studies, it was shown that when a large amount 
of the N protein was synthesized alone, it was found to 
aggregate in a concentration-dependent manner and could 
not support replication. Cotranslation of the NS protein with 
the N protein demonstrated that the NS protein can interact 
with the N protein to prevent it from aggregating and thereby 
maintain the N protein in a form competent to support RNA 
replication (22, 50). 
The available in vitro replication systems have defined the 
protein requirements for VSV RNA replication; however, 
the ability of these systems to analyze the structure-function 
relationships of various proteins involved in RNA replica-
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tion is limited. The distributive properties of the VSV RNA 
polymerase (19, 20) further complicate the analysis of the 
role of VSV polymerase in RNA replication. Attempts to 
synthesize the large polymerase L protein in vitro in a 
functional form have not been successful to date. As a result 
of this constraint, the replication events analyzed in the in 
vitro system used for our earlier studies were limited to 
analysis of replication from the input nucleocapsid templates 
which contained the polymerase. Amplification or replica-
tion of progeny nucleocapsids synthesized in the system was 
not observed. 
Because of the limitations associated with the existing in 
vitro replication systems, we developed a method to analyze 
VSV RNA replication events that would function in intact 
cells yet would maintain the capability to control the syn-
thesis of individual proteins (as could be done in vitro) but 
would be free of the limitations of the in vitro systems 
described above. In this article, we report that replication 
and amplification of the RNA of DI particles of VSV can be 
carried out in intact cells synthesizing VSV proteins directed 
by transfection of plasmid vectors containing the VSV 
genes. 
MATERIALS AND METHODS 
Cell cultures and viruses. Baby hamster kidney (BHK-21) 
cells were maintained as monolayer cultures in Eagle mini-
mal essential medium (MEM) containing 10% heat-inacti-
vated fetal bovine serum (FBS). HEp-2 cells and thymidine 
kinase-negative human 143B cells also were maintained as 
monolayers in Eagle MEM containing 5% heat-inactivated 
FBS. VSV (Indiana serotype, San Juan strain) was propa-
gated in BHK cells and used as helper virus for replication of 
the DI particle of VSV (DI-T; 27, 47). Stocks of DI-T 
particles were prepared and purified free from helper virus 
by three successive sucrose density gradient centrifugations. 
They were stored in small portions at -70°C. DI-T particle 
concentrations were calculated from measurements of hem-
agglutination of goose erythocytes (17). Recombinant vac-
cinia virus (vTF7-3) containing the T7 RNA polymerase gene 
has been described previously (15, 16) and was kindly 
provided by Bernard Moss, National Institutes of Health, 
Bethesda, Md. Stocks of vTF7-3 were prepared in HEp-2 
cells, and infectivity titers were determined by plaque assay 
on 143B cells. 
Plasmid vectors and cDNA clones. Plasmids pJS223 con-
taining the entire nucleocapsid protein (N) gene and pLHI 
containing the entire phosphoprotein (NS) gene of VSV 
(Indiana) have been described previously (23, 46) and were 
provided by R. A. Lazzarini. The N gene was excised from 
pJS223 by digestion with Xhol and cloned into the Sail site 
of pGEMI vector (Promega Biotec, Madison, Wis.) down-
stream of the T7 RNA polymerase promoter. The resulting 
plasmid was further modified to remove all but four 5' 
noncoding sequences of the N gene insert and was desig-
nated pAP-N. The plasmid pMB-NS containing the entire 
NS gene downstream of the T7 RNA polymerase promoter 
in the vector p1BI-76 (International Biotechnology Inc., 
New Haven, Conn.) was provided by M. Howard (Univer-
sity of Alabama at Birmingham). The plasmid pSV-VSLl 
containing a complete copy of the large polymerase protein 
(L) gene of VSV (Indiana) has been described previously 
(44) and was provided by M. Schubert, National Institutes of 
Health. The complete L protein gene was excised from 
pSV -VSLI by digestion with Xhol and cloned into the Sail 
site of pGEM3 vector (Promega Biotec) to obtain the plas-
mid pAP-L. This plasmid contained the L gene downstream 
of the T7 RNA polymerase promoter. Plasmids were pre-
pared by the boiling method and purified by CsCI-ethidium 
bromide equilibrium density gradient centrifugation (29). 
Plasmids were checked by electrophoresis in agarose gels to 
ensure that the majority of the DNA was supercoiled. 
Virus infection, DNA transfection, and radioactive labeling. 
HEp-2 cells were grown to about 95% confluency in 6O-mm 
plates and infected with vTF7-3 recombinant vaccinia virus 
at a mUltiplicity of infection (MOl) of 10 PFU per cell. Virus 
adsorption was allowed for 45 min at 37°C. The inoculum 
was removed and each plate was washed twice with Tris-
buffered saline (TBS) (25 mM Tris-hydrochloride [pH 7.4], 
135 mM NaCI, 50 mM KCl) containing 0.01% Ca2+ and 
Mg2 + (TBS+). The cells were then transfected with appro-
priate plasmid DNAs together with 20 IJ.g of sonicated 
salmon sperm DNA by using the calcium phosphate precip-
itation method as described previously (3). Various quanti-
ties of DNA precipitated with calcium phosphate in a volume 
of 500 IJ.I were added to washed-cell monolayers and left at 
room temperature for 30 min with occasional rocking. At the 
end ofthe period, 3 ml ofMEM containing 2.5% FBS at 37°C 
was added, and the plate was incubated at 37°C. The 
transfected cells were shocked with 10% glycerol in TBS+ as 
described previously (3) at 4 h posttransfection, washed with 
TBS+, and incubated at 37°C with 3.5 ml ofMEM-2.5% FBS 
at 37°C. For radiolabeling of proteins, cells were incubated 
in methionine-free MEM for 45 min at 37°C before being 
labeled. Labeling of proteins was usually done for 2 h in 1 ml 
of methionine-free MEM containing 20 IJ.Ci of [3sS]methio-
nine per ml. To analyze DI particle RNA replication, cells 
were superinfected at 5 h posttransfection with purified DI-T 
particles at an MOl of approximately one DI particle per 
cell. Adsorption was allowed at 37°C for 45 min. The 
inoculum was removed and replaced with 1 ml of MEM-
2.5% FBS at 37°C containing 20 IJ.Ci of [3H]uridine per mI. 
For wild-type VSV-mediated DI particle RNA replication, 
uninfected cells were coinfected with DI particles at an MOl 
of one particle per cell and with wild-type VSV at an MOl of 
3 PFU per cell and incubated as described above 
Immunoprecipitation and electrophoretic analysis of pro-
teins. Cell monolayers were washed twice with cold phos-
phate-buffered saline, scraped into cold phosphate-buffered 
saline, and collected by centrifugation at 16,000 x g for 1 
min. The cell pellet was suspended in radioimmunoprecipi-
tation assay buffer (10 mM Tris-hydrochloride [pH 7.4], 150 
mM NaCl, 1% Triton X-l00, 1% sodium deoxycholate, 0.1% 
sodium dodecyl sulfate [SDS]). Cytoplasmic extracts were 
prepared, and virus-specific proteins were immunoprecipi-
tated as described previously (35) by using either a rabbit 
polyclonal antibody raised against detergent-disrupted puri-
fied VSV or a monospecific rabbit antibody raised against an 
amino-terminal peptide from the L protein (44). Proteins 
were analyzed by electrophoresis in 10% polyacrylamide 
gels by using the buffer system of Laemmli (25) and detected 
by fluorography (8). 
Immunofluorescence. Cytoplasmic immunofluorescence 
was determined as described previously (35). Appropriate 
dilutions of rabbit anti-VSV or anti-L antibodies or both 
were used as primary antibodies, and fluorescein-conjugated 
goat anti-rabbit immunoglobulins were used as secondary 
antibodies. Immunofluorescence was examined with a fluo-
rescence microscope. 
Analysis of DI particle RNA replication. Replicated DI 
particle RNAs were analyzed by immunoprecipitation of 
nucleocapsids. Cells were harvested into 0.3 to 0.4 ml of 
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FIG. 1. SDS-polyacrylamide gel electrophoresis (PAGE) analysis of VSV proteins. (A) Subconfluent monolayers of HEp-2 cells were
infected with vTF7-3 at an MOI of 5 PFU per cell (lanes 2, 4, and 5) or 25 PFU per cell (lanes 6 and 7) or with wild-type vaccinia virus at
an MOI of 5 PFU per cell (lane 3) and then transfected with 5 (lanes 3, 4, and 6) or 25 pug (lanes 5 and 7) of pAP-N plasmid DNA. The cells
were labeled with [35S]methionine for 2 h at 10 h posttransfection. Cytoplasmic extracts were prepared, and the proteins were
immunoprecipitated with anti-VSV antibodies and analyzed by electrophoresis in 10% polyacrylamide gels containing SDS. Total
[35S]methionine-labeled proteins present in cell extracts prepared from uninfected (lane 8) or VSV-infected (lane 9) cells are shown, as are
the 14C-labeled molecular mass markers (lane 1; in kilodaltons [kDa]). (B) HEp-2 cells were infected with vTF7-3 at an MOI of 10 PFU per
cell and transfected with different amounts of pAP-N DNA (as shown above the lanes). The cells were labeled with [35S]methionine, and the
proteins were immunoprecipitated from cytoplasmic extracts and analyzed by SDS-PAGE as described above. (C) HEp-2 cells were infected
with vTF7-3 as described for panel B and subsequently transfected with 25 ,ug each of plasmids pAP-N and pMB-NS. The cells were labeled
with [35S]methionine for 2 h at various times posttransfection (as shown above the lanes). Proteins were immunoprecipitated from cytoplasmic
extracts and analyzed by SDS-PAGE as described above. (D) Expression of N, NS, and L proteins of VSV. Cells were infected with vTF7-3
at an MOI of 10 PFU per cell and transfected with 25 jig each of plasmids pAP-N, pMB-NS, and pAP-L either individually (lanes 4, 5, and
6, respectively) or together (lane 7). Proteins were labeled with [35S]methionine as described previously. Proteins were immunoprecipitated
from cytoplasmic extracts with anti-VSV antibody (lanes 3, 4, and 5) or anti-VSV antibody and anti-L (amino-terminus) antibody (lanes 6 and
7) and analyzed by SDS-PAGE as described above. Lanes 1 and 2 show [35S]methionine-labeled proteins from uninfected and VSV-infected
cells.
lysis buffer (10 mM Tris hydrochloride [pH 7.4], 1% Nonidet
P-40, 0.4% sodium deoxycholate, 10 mM EDTA) on ice and
transferred to 1.5-ml Eppendorf tubes. After being vortexed
briefly, cells were incubated on ice for 7 min. Nuclei were
removed by centrifugation at 16,000 x g for 1 min. The
clarified cytoplasmic extracts were adjusted to 0.1% SDS.
Polyclonal anti-VSV antibody (described above) was added
to the extracts, and immunoprecipitation was done overnight
at 4°C. IgGSorb (The Enzyme Center, Inc., Malden, Mass.)
washed three times in lysis buffer containing 0.1% SDS was
added, and incubation was continued for 1 h on ice. Immune
complexes were washed three times in lysis buffer contain-
ing SDS (0.1%) and NaCl (150 mM) and finally suspended in
200 RI of 10 mM Tris hydrochloride [pH 7.4]-100 mM
NaCl-1 mM EDTA containing 0.5% SDS. The immunopre-
cipitated nucleocapsids were eluted by boiling. RNAs
present in the nucleocapsids were extracted twice with
phenol and once with chloroform. Sodium chloride was
added to 0.1 M, and the RNAs were recovered by precipi-
tation with ethanol. Cell extracts not used for immunopre-
cipitation were adjusted to 0.5% SDS, and RNAs were
extracted as above. RNAs were resolved by electrophoresis
in 1.75% agarose-urea gels (49) and detected by fluorog-
raphy (26).
RESULTS
Expression of VSV proteins. Bacteriophage T7 RNA poly-
merase, expressed in the cytoplasm of cells infected with a
recombinant vaccinia virus (vTF7-3), can be used to tran-
scribe transfected plasmid DNAs that contain target genes
placed downstream of T7 RNA polymerase promoter (15,
16). We first examined the expression of VSV N protein in
cells infected with vTF7-3 and transfected with pAP-N, a
plasmid that contains the N protein gene downstream of a T7
RNA polymerase promoter. HEp-2 cells were infected with
vTF7-3, transfected with pAP-N DNA, and at 12 h post-
transfection were labeled with [35S]methionine for 2 h.
Cytoplasmic extracts were prepared, and proteins were
immunoprecipitated with anti-VSV antibody and analyzed
by electrophoresis. Results showed that vTF7-3 infected
cells transfected with pAP-N expressed a protein (Fig. 1A,
lanes 4 through 7) which comigrated with the authentic
nucleocapsid protein synthesized in VSV-infected cells (lane
9). Cells that were infected with vTF7-3 and not transfected
with pAP-N (lane 2) or cells infected with wild-type vaccinia
virus and transfected with pAP-N (lane 3) did not express the
protein. The amount of N protein expression did not in-
crease significantly as the multiplicity of vTF7-3 infection
A
KDa
200 1
68 _
29
pg of N plasmid transfected
0 | 2.21 5.51 11 27.5
Transfected Plasmids
Unin_ NN-Nn LN N +NS
M s r
[ "'N
S.
NbSm..
M
J. VIROL.
11I
'97.4 _%.
43 ltf
 I   E  
  
 vs · n  
 
. I OL 
D 
~g 01  la i  Ira lee  
 ,  , [  [ ,   -
L 
- L ~- -  
  I  I  I  
 
-43 
-----  
- 
 
. L OS-polyacr l i  l o resi  P ) l si    r t i s. ) conft t onolayer   p-  l  er  
 it  7-  t  Ol    r l  a  , ,   r   r l  a      it  il y  i i  i   
 Ol    r ll a     a  it   a  , ,     IL  a       i  .  l  
er   it  S 1 ethi i        stt sf cti . yt l i  t t  er  r ,   t  er  
unoprecipitat  it  i-VS  t i     ro resi    l a i  l  t  OS. ot l 
s 1 ethionine-l l  r t  t  l  t t   rom  i f t  a    SV-infect  a   l   n,   
 -l l  olecular ass arker  a  ;  i l  OaJ),  p-  l  er   it  -  t  Ol    r 
l   a  it  i t ounts     o    s).  l  er   it  S 1 ethionine,   
r t  er  unoprecipitat  rom i  t t     O P    e.  p-  l  er   
it  7-     el   entl  ra  it   IL    i    B- S.  l  er   
it  S 1 ethi i     t r  im  stt t      s). r t  er  unoprecipitat  rom i  
t t     O P    e.  pres   , S,   t   . ell  er   it  7-  
t  Ol    r ll  a  it   ILg   i  P- , B- S,  -   l  a  ,   
, ct l )  t r a  . r t i  er   it  s 1 et i i   b  i sl . r t  er  unoprecipitat  
rom i  t t  it  i-VS  ibo  a  , ,    i-VS  bo   t  i -t i s) bo  a    
    O P    e. es     S 1 ethionine-l el  t  rom i   SV-infect  
ll . 
 ff r   ri  r chl ri  p  . ,  onidet 
- , 4% u  ycholate,    )    
a   l pendorf s. ft r  r  
ri f , l  er  t      i . uclei er  
e   t u        i .  
ie  i  t t  er  j   1% S. 
l l al i-VS  b   ) as  
  t cts ,  unoprecipitat  as  r i t 
t . or    enter, . , alden, a s.) 
as   im    ff  t  1%  as 
,  t  as t n      . un  
ple es er  as   im    ff  t i -
  .1 )  a I  )     
 fl.l    ri  r chl ri  p  1   
a l-     t  5% S.  unopre-
e  l si  er    il . s 
t   l si  er  t  i  it  
l   it  . u  l  as 
   ,   s er    r i i
io  it  L ell t t  t   unopre-
i io  er  j   5% S ,  s er  
t   e. s er    ro resi  
 75   l    t   u
 ). 
 
xpres    r t i s. act o    l
erase, r    asm  l   it   
bi a t i i  i  7-3),     
 a  i  s t t  t  
 nst ea     l eras  oter , 
). e  i   r     r t   
l   it  -   ra  it  P- ,  
s i  t t i    r t   nst ea     
 er s  oter. p-  l  er   it  
F7-3, ra  it   A,     st
ra o  er   it  3sS] t i    . 
yt l i  t t  er  r ,  t  er  
unoprecipitat  it  i-VS  bo    
 oresis. esult   t 7-   
l  ra  it   r   r t  i . l , 
  o   hi   igrat  it   t ti  
l si  t  t   SV -infect  l  a  
. ell  t er   it  7-   t ra  
it   a    l   it  il  i i  
i   a  it   a    t r   
r t i .  ount   r t  r   t 
 i t    ultipli i   7-  o  
VOL. 64, 1990 DI PARTICLE RNA REPLICATION IN ABSENCE OF HELPER VSV 2951 
was increased from 5 (lanes 4 and 5) to 25 PFU per cell (lanes 
6 and 7). However, increasing the amount of the transfecting 
pAP-N DNA from 5 (lanes 4 and 6) to 25 II-g (lanes 5 and 7) 
resulted in increased expression of the N protein. This 
indicated that adequate amounts of T7 RNA polymerase 
were synthesized from vTF7-3 infection at an MOl of 5 PFU 
per cell. In subsequent experiments, an MOl of 10 PFU per 
cell for vTF7-3 infection was used. 
In order to examine the quantitative relationship between 
the amount of N protein made and the amount of transfected 
pAP-N DNA, HEp-2 cells were infected with vTF7-3 and 
subsequently transfected with various amounts of pAP-N 
DNA. The cells were labeled with eSS]methionine for 2 h at 
10 h posttransfection, and equal amounts of cytoplasmic 
extracts were immunoprecipitated and analyzed by electro-
phoresis. The data showed that the transfection of increasing 
amounts of the N plasmid DNA resulted in the synthesis of 
increasing amounts of the N protein (Fig. IB). Laser densi-
tometric scanning of the fluorogram indicated that the N 
protein expression was proportional to the amount of the N 
plasmid used in transfection. Similar results were obtained 
when total cytoplasmic extracts were analyzed by electro-
phoresis, showing that the quantitative relationship was not 
distorted by nonquantitative immunoprecipitation (data not 
shown). Other experiments showed that a proportional rela-
tionship exists over a range of 1 to 60 II-g of transfected 
plasmid DNA. The linearity in the amount of protein expres-
sion with the amount of transfected DNA was also found to 
exist for other VSV proteins. 
We next determined how soon after DNA transfection 
protein expression could be detected, and we also analyzed 
the rates of synthesis of proteins at various times posttrans-
fection. In these studies, HEp-2 cells were infected with 
vTF7-3 and transfected with plasmids pAP-N and pMB-NS 
(which contains the NS gene downstream of the T7 RNA 
polymerase promoter). Cells were labeled with [3sS]methi-
onine for 2 h at various times after transfection. The labeled 
proteins were immunoprecipitated from cytoplasmic ex-
tracts as described above. Both Nand NS proteins were 
synthesized as early as 6 to 8 h after the DNA was first added 
to the cells (that is, 2 to 4 h after completion of transfection) 
and continued to be synthesized at approximately the same 
rate for up to 16 h after transfection (Fig. lC). 
Since replication of VSV RNA is presumed to require the 
N, NS, and the L proteins (5, 6), we next determined 
whether all three proteins could be expressed simulta-
neously if their corresponding plasmid DNAs were trans-
fected together. HEp-2 cells were infected with vTF7-3 and 
transfected with the plasmids pAP-N, pMB-NS, and pAP-L 
either separately or together. The proteins were labeled with 
[ 3sS]methionine, immunoprecipitated, and analyzed as de-
scribed above. A fluorogram of a dried gel is shown in Fig. 
ID. The N, NS, and L proteins were expressed in cells when 
their corresponding plasmid DNAs were transfected individ-
ually (lanes 4 through 6, respectively). These proteins comi-
grated with the authentic proteins synthesized in VSV-
infected cells (lane 2). Simultaneous transfection of all three 
plasmid DNAs resulted in expression of all three proteins 
(lane 7) in amounts that were indistinguishable from those 
achieved when individual plasmids were transfected sepa-
rately. These data showed that transfection of75 II-g (total) of 
DNA was not inhibitory to protein expression and that the 
expression of one protein did not interfere with the expres-
sion of other proteins. 
Immunofluorescent staining of transfected HEp-2 cells 
expressing VSV proteins showed that approximately 40% of 
the cells expressed VSV proteins. The percentage of cells 
expressing VSV proteins remained approximately the same 
whether 5 or 50 II-g (total) of anyone or all three plasmid 
DNAs were used for transfection (data not shown). We 
conclude that this may represent the maximum number of 
cells that are competent for transformation by this method 
(9). These results indicated that when all three plasmid 
DNAs were used in transfection, 40% of the cells were 
transfected with all three plasmid DNAs and expressed all 
three VSV proteins. In cells infected with VSV at an MOl of 
3 PFU per cell, approximately 90 to 95% of the cells 
expressed VSV proteins at 6 h posttransfection (data not 
shown). 
Immunoprecipitation as a method of analysis of newly 
replicated RNAs. The genomic and antigenomic RNAs of 
VSV and its DI particles are found only associated with N 
protein in the form of nucleocapsid structures that are 
resistant to nucleolytic digestion (45). During replication, the 
template RNAs (in the form ofnucleocapsids) are replicated 
to form nuclease-resistant nucleocapsids, and therefore, 
micrococcal nuclease has been used widely as an assay for 
newly replicated RNAs. Using this assay, we were able to 
demonstrate the replication of DI particle RNA in cells 
expressing VSV proteins; however, because of the presence 
of detergents in the lysis buffer used to prepare cytoplasmic 
extracts, the assay was insensitive and unreliable. To cir-
cumvent this problem, we used immunoprecipitation of 
newly replicated nucleocapsids from the cytoplasmic ex-
tracts with anti-nucleocapsid protein antibody as an alterna-
tive method of analysis. In order to determine how quanti-
tative this method of analysis is, we labeled RNAs with 
eH]uridine in VSV-infected cells or VSV- and DI particle-
coinfected cells in the presence of dactinomycin. The labeled 
RNAs present in the immunoprecipitated nUcleocapsids 
were recovered by phenol extraction and analyzed by elec-
trophoresis in an agarose-urea gel (Fig. 2). Immunoprecipi-
tation of cytoplasmic extracts from VSV -infected cel1s 
showed the presence of only the labeled 40S virion RNA 
which is always found in nucleocapsid structures (lane 2). 
The total cytoplasmic extracts from these cel1s also con-
tained all five VSV mRNAs (lane 1), which were not 
immunoprecipitated. Similarly, immunoprecipitation of the 
extracts of cells coinfected with VSV and DI particles 
showed that only the genomic RNAs of VSV and the DI 
particles were immunoprecipitated (lanes 4 through 6), 
whereas five VSV mRNAs, which were also present in the 
total cytoplasmic extract (lane 3), were not immunoprecipi-
tated. A quantitative analysis of the amount of immunopre-
cipitated DI particle RNAs by densitometric scanning indi-
cated that at least 80% of the total nucleocapsid RNAs could 
be recovered by immunoprecipitation and that increasing the 
amount of antibody used for immunoprecipitation did not 
increase the recovery. The results of the above experiment 
thus showed that immunoprecipitation of nucleocapsids can 
be used as a specific method of analysis of newly replicated 
and encapsidated virus-specific RNAs and that the method is 
sensitive and quantitative. 
Replication of DI particle RNA in ceUs expressing VSV 
proteins. The ability of VSV proteins expressed in the 
vaccinia virus-T7 RNA polymerase-based expression sys-
tem to support the replication of DI particle RNA was 
investigated. The basic protocol to analyze DI particle RNA 
replication in the system is outlined in Fig. 3. HEp-2 cells 
were infected with vTF7-3 and transfected with plasmid 
DNAs containing the genes for the VSV proteins N, NS, and 
L. The transfected cells were superinfected with DI particles 
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FIG. 2. Immunoprecipitation of VSV nucleocapsids. HEp-2 cells
were infected with VSV or VSV and DI particles and labeled with
[3H]uridine for 6 h in the presence of 4 ,ug of dactinomycin per ml.
Cytoplasmic extracts were prepared, and the nucleocapsids present
in the extracts were immunoprecipitated with anti-VSV antibody as
described in Materials and Methods. The labeled RNAs recovered
from immunoprecipitated nucleocapsids were analyzed by electro-
phoresis in a 1.75% agarose-urea gel. Total RNA (lanes 1 and 3) or
RNA present in nucleocapsids from VSV-infected (lanes 1 and 2) or
VSV and DI particle-coinfected (lanes 3 through 6) cells immuno-
precipitated with 3 (lanes 2 and 4), 5 (lane 5), or 10 RI (lane 6) or
anti-VSV antibody are shown. - and + represent the genomic and
antigenomic RNAs, respectively, of DI particles. L, G, N, and
M/NS represent the mRNAs for the corresponding proteins.
of VSV at 5 h posttransfection. Infected cells were exposed
to [3H]uridine for 6 h to label newly replicating RNAs.
Cytoplasmic extracts were prepared, VSV-specific nucleo-
capsids were immunoprecipitated, and the RNAs were re-
covered and analyzed by electrophoresis. DI particles in
cells without helper VSV were unable to replicate because of
the lack of genetic information to program the synthesis of
proteins needed for replication (Fig. 4, lane 1). These parti-
cles replicated only in the presence of wild-type helper virus
(lane 2) that provided the proteins required for replication.
These data also demonstrated that the purified DI particles
did not contain any contaminating helper virus which could
support DI particle RNA replication. Replication of DI
particle RNA was not readily detectable in cells expressing
N, NS, and L proteins either individually (lanes 4 to 6) or in
any combination of two of the three proteins together (lanes
7 to 9). However, in the presence of all three of the VSV
proteins, replication of DI particle RNA was demonstrated,
and both the positive- and negative-sense RNAs were syn-
thesized (lane 10). This demonstrated not only that the input
negative-sense DI nucleocapsid RNA replicated to form
positive-sense RNA, but also that the positive-sense RNA
was assembled with the nucleocapsid protein and the newly
synthesized polymerase to form an active template for the
synthesis of new negative-sense RNA.
HEp-2 Cells
Infect with vTF7-3
,370C, 45 min
Transfect with CaPOlDNA
precipitates
RT, 30min
Add MEM and incubate
37 C, 4 hours
Glycerol shock,wash,add
MEM and incubate
l370C, 1 hour
Supertnfect with Dl
particles
137OC, 45 min
Add MEM containing
3H -uridine
370C, 6 hours
Prepare cell extract,
immunoprecipitate nucleocapsids,
recover RNA,and analyse in
agarose - urea gel
FIG. 3. Protocol for analysis of DI particle RNA replication in
cells expressing VSV proteins. RT, Room temperature.
The lack of detectable DI particle RNA replication in cells
expressing only the N and NS proteins was surprising at
first, since we had reported that these proteins alone were
able to support replication of DI nucleocapsids in vitro (22).
We therefore examined this experimental situation more
closely by performing the transfection under conditions in
which a constant amount of N protein and various amounts
of NS proteins were synthesized. After long exposure of the
fluorographed gel, the products of DI particle RNA replica-
tion could be detected, even in the absence of newly
synthesized L protein (data not shown). Both positive- and
negative-sense RNAs were synthesized under these condi-
tions, in amounts approximately 0.01 to 0.1% of those made
in the presence of N, NS, and L proteins. Thus, these results
show that RNA replication can be observed in the presence
of the N and NS proteins as has been described previously
for the in vitro system (22). The difference in amounts of
replicated RNA detected can be attributed to the fact that in
the in vitro system we measured the products of replication
of a large amount of input template with little, if any,
subsequent amplification. The system described here, on the
other hand, supports several rounds of replication and
concomitant RNA amplification of input as well as newly
assembled templates because of the synthesis of functional
polymerase.
A significant amount of heterodisperse radioactive RNA
was immunoprecipitated from cells expressing the N protein
alone (lane 4). This heterodisperse RNA was either absent or
less pronounced in lanes containing material from cells
expressing other proteins separately or together (lanes 5
through 10). Further experiments have shown that this RNA
is derived from the vaccinia virus-infected host cells and is
bound to the N protein expressed in the absence of other
VSV proteins. This binding is abrogated or reduced when
the NS or L or both proteins are coexpressed with the N
protein, suggesting that interactions with these proteins
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DI PARTICLE RNA REPLICATION IN ABSENCE OF HELPER VSV
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8 9 10
FIG. 4. Replication of DI particle RNA in cells expressing VSV
proteins. HEp-2 cells in 60-mm plates were infected with vTF7-3
and transfected with 25 ,ug each of plasmids pAP-N, pMB-NS, and
pAP-L either separately or in combination. After superinfection
with DI particles, the cells were labeled with [3H]uridine, extracts
were prepared, nucleocapsids were immunoprecipitated, and the
labeled RNAs were analyzed by electrophoresis. DI particle RNA
replication products without (lane 1) or with (lane 2) helper VSV and
in vTF7-3-infected cells transfected with no plasmid (lane 3) or with
pAP-N (lane 4), pMB-NS (lane 5), pAP-L (lane 6), pAP-N and
pMB-NS (lane 7), pAP-N and pAP-L (lane 8), pMB-NS and pAP-L
(lane 9), or pAP-N, pMB-NS, and pAP-L (lane 10) DNA are shown.
Symbols: - and +, genomic and antigenomic RNAs, respectively,
of DI particles.
enhance the specificity of the N protein binding to VSV
RNA. Similar results were obtained in vitro by Masters and
Banerjee (31), who concluded that the NS protein, by
interacting with the N protein, confers specificity on the N
protein to bind to VSV RNA. Our result extends these
conclusions by suggesting that the polymerase L protein also
confers specificity for RNA binding on the N protein.
Optimization of DI particle RNA replication. Although DI
particle RNA replication was demonstrated in cells express-
ing the three VSV proteins, the amount of replication in the
initial experiments was significantly lower than that ob-
served with helper virus-mediated DI particle RNA replica-
tion (compare lanes 2 and 10 in Fig. 4). In VSV-infected
cells, the molar ratio of the proteins involved in viral RNA
transcription and replication is maintained by the gene order
and the sequential nature of transcription of their mRNAs (1,
4). An imbalance in the molar ratio of these proteins inter-
feres with efficient replication of VSV (32). We considered
that the low level of DI particle RNA replication in this initial
experiment might therefore reflect an imbalance in the molar
ratio of these proteins. To test this possibility, DI particle
RNA replication in the system was optimized. The amounts
of individual proteins synthesized were controlled by trans-
fecting various amounts of plasmids for the corresponding
proteins, and the efficiency of replication under each condi-
tion was analyzed. Initially, the amount of the L protein
needed for optimal levels of DI particle RNA replication was
determined. HEp-2 cells infected with vTF7-3 were trans-
fected with various amounts of pAP-L DNA in addition to a
constant amount of pAP-N and pMB-NS DNA (25 ,ug each).
After superinfection of these cells with DI particles, the
newly replicating RNAs were labeled with [3H]uridine and
analyzed as described above. The results (Fig. 5A) showed
that as the amount of polymerase L plasmid DNA was
increased in transfection, the amount of DI particle RNA
replication initially increased and then decreased signifi-
cantly. Densitometric scanning of the fluorogram (Fig. 5D)
indicated that the DI particle RNA replication was maximal,
with only 5 p,g of pAP-L DNA transfected per 3 x 106 cells
(Fig 5A, lane 4). With optimal amounts of only the L protein,
but not the N or NS proteins, the amount of DI particle RNA
replication represented approximately 40 to 50% of the
amount of DI particle RNA replication mediated by helper
VSV (lane 1). In order to optimize the replication for the NS
protein, the experiment was performed by transfecting var-
ious amounts of pMB-NS DNA in addition to constant
amounts of pAP-N DNA (25 ,g) and pAP-L DNA (5 jig).
The results of the experiment (Fig. 5B and E) showed that
the DI particle RNA replication was maximal when 10 jig of
pMB-NS DNA was used per 3 x 106 cells (Fig. SB, lane 5),
whereas increasing or decreasing the amount of the DNA
resulted in reduced amounts of RNA replication. The
amount of DI particle RNA replication with optimized
amounts of the L and NS proteins was approximately
twofold greater than the amount of replication obtained with
helper VSV (Fig. SB, lane 1). By using the optimized
amounts of pAP-L (5 ,ug) and pMB-NS (10 ,ug) DNA, the
amount of pAP-N DNA needed for optimal replication of DI
particle RNA was determined. The results of this experiment
are shown in Fig. SC, and the densitometric scanning of the
fluorogram is shown in Fig. SF. As the amount of pAP-N
DNA was increased, the amount of replication increased,
reached a plateau, and then decreased. However, the
amount of DI particle RNA replication was not affected by
increasing the amount of transfected pAP-N DNA as much
as it was by increasing the amount of transfected pAP-L or
pMB-NS DNA. Results of densitometric scanning of the
fluorogram showed that replication was maximal when 15 to
25 ,ug of pAP-N DNA was used in transfection.
We next compared the relative amounts of DI particle
RNA replication in cells expressing the three VSV proteins
under optimized conditions with that supported by helper
virus. Results of the densitometric scanning of the fluoro-
gram shown in Fig. 6A showed that the amount of DI particle
RNA replication supported by the optimized amounts of the
three VSV proteins (lane 2) was approximately four times
greater than that obtained with the helper VSV (lane 1).
Considering that only about 40% of the cells expressed all
three proteins (as described above), we estimate that the
amount of DI particle RNA replication per cell was at least
8 to 10 times greater than that obtained with helper VSV.
The amount of each protein synthesized in cells under the
optimized conditions of RNA replication was determined by
analyzing total [35S]methionine-labeled proteins in cytoplas-
mic extracts of cells that were infected with VSV or trans-
fected with plasmid DNAs. The total amount of the L, NS,
and N proteins synthesized in transfected cells (Fig. 6B, lane
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FIG. 5. Optimization of DI particle RNA replication in cells expressing VSV proteins. (A) Optimization with L protein. HEp-2 cells were
infected with vTF7-3 and subsequently transfected with 25 jig each of plasmids pAP-N and pMB-NS and various amounts of pAP-L as shown.
DI particle superinfection, radioactive labeling, and analysis of replicated RNAs were done as described in the legend to Fig. 4. RNA
replication products supported by various amounts of the L plasmid DNA are shown. Lane 1 shows the replication products supported by
helper VSV. (B) Optimization with NS protein. The experiment was performed as described above, except that transfection was done with
25 jig of pAP-N, 5 jig of pAP-L DNA, and various amounts of pMB-NS DNA as shown. DI particle RNA replication products supported by
various amounts of the NS plasmid are shown. DI particle RNA replication supported by helper virus is shown in lane 1. (C) Optimization
with N protein. The experiment was performed in a manner similar to that described above, but the transfection was done with 5 jig of pAP-L
10 jig of pMB-NS DNA, and various amounts of pAP-N DNA as shown above the lanes. DI particle RNA products supported by various
amounts of the N plasmid DNA are shown. Panels D, E, and F show the results of densitometric tracing of fluorograms shown in panels A,
B, and C, respectively. Symbols: - and +, genomic and antigenomic RNAs, respectively, of DI particles.
4) was less than that in VSV-infected cells (lane 2). The
molar ratios of the L, NS, and N proteins synthesized under
optimal conditions of RNA replication were approximately
1:200:200, respectively, as determined by densitometric
scanning of the fluorogram and taking into account the
number of methionine residues in each protein. In VSV-
infected HEp-2 cells, this ratio was approximately 1:25:45.
Kinetics of DI particle RNA replication. Having established
that the DI RNA replication is more efficient in cells express-
ing the N, NS, and L proteins than in cells infected with
helper VSV, we compared the kinetics of synthesis of the DI
RNAs in both systems. Accordingly, one set of plates of
HEp-2 cells was infected with vTF7-3 and transfected with
optimal amounts of the three plasmids together. After super-
infection with DI particles, the cells were labeled with
[jH]uridine for different lengths of time. Another set of
plates of HEp-2 cells was coinfected with VSV and DI
particles and labeled similarly. The labeled RNAs were
analyzed by immunoprecipitation and electrophoresis. DI
RNA replication could be detected easily in cells expressing
the three VSV proteins (Fig. 7A) within 30 min of DI particle
superinfection (lane 6), whereas replication was barely de-
tectable in the first hour of VSV and DI particle coinfection
(lane 2). In subsequent experiments, RNA replication was
detected with shorter labeling times, as early as 10 min, after
DI particle superinfection of cells expressing the three VSV
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FIG. 6. (A) Comparison of levels of DI particle RNA replication
in cells expressing the three VSV proteins and in cells supported by
helper virus. Parallel cultures of HEp-2 cells were infected with
VSV and DI particles (lane 1) or were infected with vTF7-3 and
transfected with pAP-N (15 p.g), pMB-NS (10 jig), and pAP-L (5 jig)
and subsequently superinfected with DI particles (lane 2) as de-
scribed in the text. Radioactive labeling with [3H]uridine and
analysis of labeled RNAs by immunoprecipitation and electropho-
resis were done as described in the legend to Fig. 4. (B) Synthesis of
the VSV proteins under conditions of optimal DI RNA replication.
HEp-2 cells were infected with VSV at an MOI of 3 PFU per cell or
were mock infected. Another set of cells were infected with vTF7-3
and subsequently transfected with the same amounts of the three
plasmid DNAs as were used for Fig. 6A or were mock transfected.
Cells were labeled with [35S]methionine for 2 h at 4 h after VSV
infection or 8 h after DNA transfection. Total proteins present in
equal proportions of cytoplasmic extracts from mock-infected (lane
1), VSV-infected (lane 2), mock-transfected (lane 3), or transfected
(lane 4) cells were analyzed by SDS-polyacrylamide gel electropho-
resis.
proteins (data not shown). Densitometric scanning (Fig. 7B)
of the fluorogram showed that the synthesis of DI RNA
increased exponentially in both systems; however, the rate
of synthesis was lower in cells infected with helper virus
than in cells expressing the three VSV proteins.
DISCUSSION
In this article, we report that replication and amplification
of DI particle RNA in cells required the N, NS, and L
proteins of VSV. This work provides the first direct evidence
that only these three proteins are needed for replication and
assembly of DI particle RNAs into active nucleocapsids for
further amplification. DI particle RNA replication in cells
expressing the three VSV proteins was found to be more
efficient than that in cells infected with wild-type helper
VSV. Kinetic analysis showed that DI particle RNA repli-
cation began soon after the infecting DI particles entered the
cells expressing the three VSV proteins, presumably be-
cause, under the conditions used (Fig. 3), the proteins
needed for DI particle RNA replication already had been
synthesized and were present in the amounts necessary for
RNA replication.
The expression ofVSV proteins was carried out in cells by
the method developed by Fuerst et al. (15, 16). Several
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FIG. 7. Kinetics of DI particle RNA replication. (A) Parallel
cultures of HEp-2 cells were infected with VSV and DI particles
(lanes 1 through 5) or infected with vTF7-3, transfected with three
plasmids as described in the legend to Fig. 6, and subsequently
superinfected with DI particles (lanes 6 through 10). Cells were
labeled with [3H]uridine for various lengths of time as shown above
the lanes. Cytoplasmic extracts were prepared, and the labeled
RNAs were analyzed as described for Fig. 4. DI RNA replication
products after various lengths of time of labeling are shown.
Symbols: - and +, genomic and antigenomic RNAs, respectively,
of DI particles. (B) Results of densitometric scanning of the fluoro-
gram shown in panel A. Symbols: 0, replication supported by
helper virus; O, replication supported by N, NS, and L proteins
expressed in the cells.
aspects of this protein expression system were particularly
valuable to the analysis of the DI particle RNA replication.
VSV proteins were expressed soon after transfection of
plasmid DNA and continued to be synthesized at a constant
rate for at least 16 h posttransfection. The amount of each
protein expressed could be controlled by the amount of the
corresponding plasmid DNA used in transfection. When the
plasmid DNAs containing the N, NS, and the L genes were
transfected together, the amount of each protein expressed
was similar to that obtained when corresponding amounts of
individual plasmid DNAs were transfected. Thus, the ability
to control protein expression in these cells provided flexi-
bility in defining the requirements for optimal levels of RNA
replication.
The molar ratio of the VSV proteins in infected cells is
regulated by the highly conserved gene order and the se-
quential and attenuated nature of transcription of their
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1 2
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mRNAs (1, 4, 24). If the molar ratio is disturbed, for 
example, by expression of high levels of recombinant L 
protein in cells followed by superinfection of the cells with 
temperature-sensitive polymerase mutants of VSV, efficient 
replication and complementation of mutant virus is not 
observed (32). However, cells expressing low levels of 
recombinant L protein allow efficient replication and com-
plementation of the mutant virus, apparently because the 
balance of the viral proteins is not significantly disturbed 
(32). The ability to control the relative molar amounts of the 
proteins synthesized by transfection of plasmid DNAs is 
demonstrated in Fig. 1. The effect of altering the amounts of 
input plasmids relative to one another on the levels of DI 
particle RNA replication is demonstrated dramatically. The 
results presented in Fig. 5 further emphasize the importance 
of synthesizing appropriate relative amounts of the three 
proteins for optimal levels ofreplication ofDI particle RNA. 
When appropriate relative amounts of the three VSV pro-
teins were synthesized, the amount of DI particle RNA 
replication was found to be at least 8- to 10-fold greater than 
that obtained with the wild-type helper VSV. This high level 
of DI particle RNA replication in cells expressing the three 
VSV proteins was not due to the expression of greater 
amounts of the proteins compared with that in cells infected 
with the helper virus (Fig. 6B). It may be due to the fact that 
no competition exists between the DI particle RNA and the 
wild-type VSV RNA in cells expressing the three VSV 
proteins, whereas during the helper virus-mediated replica-
tion, the DI RNAs and the full-length VSV RNAs compete 
for the same pool of viral proteins for replication. However, 
an alternative explanation is suggested by the molar L:NS:N 
ratios that were found to be optimal for RNA replication. 
Rather than the L:NS:N ratios of 1:25:45 which exist during 
VSV-supported DI particle RNA replication, we found L: 
NS:N ratios of 1:200:200 to be optimal for RNA replication 
in the vector-supported system. Since the relative amounts 
of viral proteins that are found in the natural situation are 
presumably the result of natural selection for the maximum 
production of infectious virus particles, they may be subop-
timal for the two individual steps in this overall process for 
which we have assayed, RNA replication and encapsidation. 
These data and data derived previously from the analyses of 
the protein requirements for RNA replication carried out in 
vitro (22) show that when RNA replication is examined apart 
from other processes, such as transcription and virion as-
sembly, the optimal molar NS:N ratio is between 0.5 and 1. 
Levels of NS relative to N that exceed 1 are inhibitory to 
RNA replication. Thus, these data show that the levels of 
RNA replication may be controlled by the molar ratio of NS 
to N. Although the stoichiometry of the complexes of the N 
and NS proteins during vector-supported replication has not 
yet been determined, multiple complexes of these two pro-
teins exist in VSV-infected cells (38, 40) as well as in vitro 
(12, 30). At present, attempts are being made to determine 
the stoichiometry of the complexes of the Nand NS proteins 
that support DI particle RNA replication in cells expressing 
the three VSV proteins. 
The replication of both positive- and negative-sense RNAs 
in cells expressing the N, NS, and L proteins demonstrated 
that functional proteins were assembled with newly synthe-
sized RNAs to form active nucleocapsid templates that were 
able to undergo multiple rounds of replication. As a result, 
the initial products of replication were amplified. In contrast, 
replication in the presence of the Nand NS proteins was 
limited to only a few rounds of replication because of the 
redistribution of a limited number of functional polymerase 
J. VIROL. 
molecules derived from the input templates. Thus, the DI 
particle RNA replication in the presence of the N and the NS 
proteins in cells is analogous to the replication in the in vitro 
system (48), in which the products are the result of replica-
tion of input templates. The quantitative difference in the 
amount of products can be attributed to the amount of input 
templates used in the two systems. The amount of templates 
used in the in vitro system is approximately 1,000 to 5,000 
times greater than that used in the above-mentioned cell-
based replication system, in which the MOl is approximately 
1 DI particle per cell. On the other hand, RNA replication in 
cells expressing all three VSV proteins mimics the replica-
tion supported by helper VSV in that the products result 
from multiple rounds of replication of input templates as well 
as of newly synthesized and assembled templates. 
The replication system that we have described above can 
be used to study the mechanisms and the requirements for 
VSV RNA replication. This system will be particularly 
useful for detailed structure-function analysis of viral pro-
teins involved in RNA replication. It has been shown already 
by using the recombinant vaccinia virus-T7 RNA polymer-
ase system that the matrix protein (M) and the glycoprotein 
(G) of VSV can be expressed in functional forms (28, 52), 
and therefore, this system can be used further to express all 
five structural proteins of VSV in order to analyze the 
interaction of the VSV proteins during maturation and 
budding of virions. We are optimistic that this replication 
system may also be used to express synthetic VSV RNAs 
and proteins to allow encapsidation of the transcripts in 
cells. This would enable us to identify and analyze the 
regulatory elements present in the VSV genome that control 
the transcription and replication processes of VSV. 
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